Concepedia

Danielle Murphy

DM

Statistics

Publications

22

Citations

3K

H-Index

20

Active since

2006

Affiliations

Pfizer (United States)(Current)

Memorial Sloan Kettering Cancer Center

Peter MacCallum Cancer Centre

University of Pennsylvania

Ignyta (United States)

Danielle Murphy is an author at Pfizer (United States) specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2006–2024

22

Publications

22

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

Michael Dews, Asal Homayouni, Duonan Yu et al. · Nature Genetics · 2006 · 1K citations · Full text

, , +6

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Alexander Drilon, Jeffrey W. Clark, Jared Weiss et al. · Nature Medicine · 2020 · 364 citations · Full text

, , +9

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 322 citations · Full text

Crizotinib in Patients With MET-Amplified NSCLC

D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark et al. · Journal of Thoracic Oncology · 2021 · 163 citations · Full text

Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)

Danielle Murphy, Sosina Makonnen, Wiem Lassoued et al. · American Journal Of Pathology · 2006 · 156 citations · Full text

, , +7

1–5 of 22